Shots: Dova Pharmaceuticals to pay Salix Pharmaceuticals, a quarterly fee on the US sales. Salix to deploy ~100 specialists for promotion of Doptelet which is expected to launch in mid-Oct 2018 Doptelet is approved by FDA on 21 May, 2018 for thrombocytopenia in adult patients with chronic liver disease (CLD). The approval is based on […]Read More
